Sign in
4

Changes in Ownership

Ovid Therapeutics Inc. Filed Acc 0001886431-26-000004

Director acquired 17,578 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Fitzgerald Kevin Joseph Director 2026-04-07 Grant or award +17,578 $2.56 $45,000 17,578 D
Loading xslF345X06/form4-04092026_050401.xml…